Abstract
Key Points Daily nicotinamide significantly reduced the incidence of nonmelanoma skin cancers in high‐risk individuals. It is reasonable to recommend nicotinamide in high‐risk individuals along with continued sunscreen use and regular skin checks in motivated patients. Further studies including longer follow‐up and a wider population of patients to assess for any unforeseen safety issues as well as efficacy are indicated.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
